Dennis N. Stanley

Dennis N. Stanley

Auto-generated profile, based on publicly available information

Dennis N. Stanley

Department of Radiation Oncology The University of Alabama at Birmingham Birmingham Alabama USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2017 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
DSDennis N. Stanley
Dennis N. Stanley
KMKristen A. McConnell
Kristen A. McConnell
NKNeil Kirby
Neil Kirby
AGAlonso N. Gutiérrez
Alonso N. Gutiérrez
NPNikos Papanikolaou
Nikos Papanikolaou
KRKarl Rasmussen
Karl Rasmussen
Purpose: Historically, the process of positioning a patient prior to imaging verification used a set of permanent patient marks, or tattoos, placed subcutaneously. After aligning to these tattoos, plan specific shifts are applied and the position is verified with imaging, such as cone‐beam computed tomography (CBCT). Due to a variety of factors, these marks may deviate from the desired position or it may be hard to align the patient to these marks. Surface‐based imaging systems are an alternative method of verifying initial positioning with the entire skin surface instead of tattoos. The aim of this study was to retrospectively compare the CBCT‐based 3D corrections of patients initially positioned with tattoos against those positioned with the C‐RAD CatalystHD surface imager system.Methods: A total of 6000 individual fractions (600–900 per site per method) were randomly selected and the post‐CBCT 3D corrections were calculated and recorded. For both positioning methods, four common treatment site combinations were evaluated: pelvis/lower extremities, abdomen, chest/upper extremities, and breast. Statistical differences were evaluated using a paired sample Wilcoxon signed‐rank test with significance level of <0.01.Results: The average magnitudes of the 3D shift vectors for tattoos were 0.9 ± 0.4 cm, 1.0 ± 0.5 cm, 0.9 ± 0.6 cm and 1.4 ± 0.7 cm for the pelvis/lower extremities, abdomen, chest/upper extremities and breast, respectively. For the CatalystHD, the average magnitude of the 3D shifts for the pelvis/lower extremities, abdomen, chest/upper extremities and breast were 0.6 ± 0.3 cm, 0.5 ± 0.3 cm, 0.5 ± 0.3 cm and 0.6 ± 0.2 cm, respectively. Statistically significant differences (P < 0.01) in the 3D shift vectors were found for all four sites.Conclusion: This study shows that the overall 3D shift corrections for patients initially aligned with the C‐RAD CatalystHD were significantly smaller than those aligned with subcutaneous tattoos. Surface imaging systems can be considered a viable option for initial patient setup and may be preferable to permanent marks for specific clinics and patients.

15 March 2023 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
DSDennis N. Stanley
Dennis N. Stanley
JHJoseph Harms
Joseph Harms
JPJoel A. Pogue
Joel A. Pogue
JBJean‐Guy Belliveau
Jean‐Guy Belliveau
SMSamuel R. Marcrom
Samuel R. Marcrom
CCCarlos E. Cardenas
Carlos E. Cardenas
Purpose: Online Adaptive Radiation Therapy (oART) follows a different treatment paradigm than conventional radiotherapy, and because of this, the resources, implementation, and workflows needed are unique. The purpose of this report is to outline our institution's experience establishing, organizing, and implementing an oART program using the Ethos therapy system.Methods: We include resources used, operational models utilized, program creation timelines, and our institutional experiences with the implementation and operation of an oART program. Additionally, we provide a detailed summary of our first year's clinical experience where we delivered over 1000 daily adaptive fractions. For all treatments, the different stages of online adaption, primary patient set‐up, initial kV‐CBCT acquisition, contouring review and edit of influencer structures, target review and edits, plan evaluation and selection, Mobius3D 2nd check and adaptive QA, 2nd kV‐CBCT for positional verification, treatment delivery, and patient leaving the room, were analyzed.Results: We retrospectively analyzed data from 97 patients treated from August 2021–August 2022. One thousand six hundred seventy seven individual fractions were treated and analyzed, 632(38%) were non‐adaptive and 1045(62%) were adaptive. Seventy four of the 97 patients (76%) were treated with standard fractionation and 23 (24%) received stereotactic treatments. For the adaptive treatments, the generated adaptive plan was selected in 92% of treatments. On average(±std), adaptive sessions took 34.52 ± 11.42 min from start to finish. The entire adaptive process (from start of contour generation to verification CBCT), performed by the physicist (and physician on select days), was 19.84 ± 8.21 min.Conclusion: We present our institution's experience commissioning an oART program using the Ethos therapy system. It took us 12 months from project inception to the treatment of our first patient and 12 months to treat 1000 adaptive fractions. Retrospective analysis of delivered fractions showed that the average overall treatment time was approximately 35 min and the average time for the adaptive component of treatment was approximately 20 min.

22 December 2022 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
XZXiaodong Zhao
Xiaodong Zhao
DSDennis N. Stanley
Dennis N. Stanley
CCCarlos E. Cardenas
Carlos E. Cardenas
JHJoseph Harms
Joseph Harms
RPRichard A. Popple
Richard A. Popple
Background: The clinical introduction of dedicated treatment units for online adaptive radiation therapy (OART) has led to widespread adoption of daily adaptive radiotherapy. OART allows for rapid generation of treatment plans using daily patient anatomy, potentially leading to reduction of treatment margins and increased normal tissue sparing. However, the OART workflow does not allow for measurement of patient‐specific quality assurance (PSQA) during treatment delivery sessions and instead relies on secondary dose calculations for verification of adapted plans. It remains unknown if independent dose verification is a sufficient surrogate for PSQA measurements.Purpose: To evaluate the plan quality of previously treated adaptive plans through multiple standard PSQA measurements.Methods: This IRB‐approved retrospective study included sixteen patients previously treated with OART at our institution. PSQA measurements were performed for each patient's scheduled and adaptive plans: five adaptive plans were randomly selected to perform ion chamber measurements and two adaptive plans were randomly selected for ArcCHECK measurements. The same ArcCHECK 3D dose distribution was also sent to Mobius3D to evaluate the second‐check dosimetry system.Results: All (n = 96) ion chamber measurements agreed with the planned dose within 3% with a mean of 1.4% (± 0.7%). All (n = 48) plans passed ArcCHECK measurements using a 95% gamma passing threshold and 3%/2 mm criteria with a mean of 99.1% (± 0.7%). All (n = 48) plans passed Mobius3D second‐check performed with 95% gamma passing threshold and 5%/3 mm criteria with a mean of 99.0% (± 0.2%).Conclusion: Plan measurement for PSQA may not be necessary for every online‐adaptive treatment verification. We recommend the establishment of a periodic PSQA check to better understand trends in passing rates for delivered adaptive treatments.

23 October 2020 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
ECElizabeth L. Covington
Elizabeth L. Covington
DSDennis N. Stanley
Dennis N. Stanley
JFJohn B. Fiveash
John B. Fiveash
ETEvan M. Thomas
Evan M. Thomas
SMSamuel R. Marcrom
Samuel R. Marcrom
RPRichard A. Popple
Richard A. Popple
Purpose: To report on the use of surface guided imaging during frameless intracranial stereotactic radiotherapy with automated delivery via HyperArcTM (Varian Medical Systems, Palo Alto, CA).Methods: All patients received intracranial radiotherapy with HyperArcTM and were monitored for intrafraction motion by the AlignRT® (VisionRT, London, UK) surface imaging (SI) system. Immobilization was with the EncompassTM (Qfix, Avondale, PA) aquaplast mask device. AlignRT® log files were correlated with trajectory log files to correlate treatment parameters with SI reported offsets. SI reported offsets were correlated with gantry angle and analyzed for performance issues at non‐zero couch angles and during camera‐pod blockage during gantry motion. Demographics in the treatment management system were used to identify race and determine if differences in SI reported offsets are due to skin tone settings.Results: A total of 981 fractions were monitored over 14 months and 819 were analyzed. The median AlignRT® reported motion from beginning to the end of treatment was 0.24 mm. The median offset before beam on at non‐zero couch angles was 0.55 mm. During gantry motion when camera pods are blocked, the median magnitude was below 1 mm. Median magnitude of offsets at non‐zero couch angles was not found to be significantly different for patients stratified by race.Conclusions: Surface image guidance is a viable alternative to scheduled mid‐treatment imaging for monitoring intrafraction motion during stereotactic radiosurgery with automated delivery.

3 March 2025 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
JDJingwei Duan
Jingwei Duan
JPJoel A. Pogue
Joel A. Pogue
DSDennis N. Stanley
Dennis N. Stanley
SSSui Shen
Sui Shen
NVNatalie N. Viscariello
Natalie N. Viscariello
JHJoseph Harms
Joseph Harms
Purpose/objectives: Recent technological advancements have increased efficiency for clinical deliverability of online‐adaptive‐radiotherapy (oART). Previous cone‐beam‐computed‐tomography (CBCT) generations lacked the ability to provide reliable Hounsfield‐units (HU), thus requiring oART workflows to rely on synthetic‐CT (sCT) images derived through deformable‐image‐registration (DIR) between the planning CT (pCT) and the daily CBCT. These sCTs are prone to errors stemming from DIR, potentially contributing to dosimetric errors. This study aims to evaluate the capability of direct dose calculation using a novel CBCT platform, HyperSight (Varian‐Medical‐Systems), as an alternative for sCT.Methods/materials: To validate the HyperSight iterative CBCT (HS‐iCBCT) HU accuracy, 125 kV and 140 kV HS‐iCBCT calibration curves were benchmarked against a pCT calibration curve. To determine the clinical impact of HS‐iCBCT compared to sCT, daily adaptive sessions from 47 oART fractions from 10 patients were analyzed. For these patients, HS‐iCBCT was acquired for daily adaption, and sCT was generated as part of the standard adaptive workflow. After daily adaption, dose was recalculated directly using the HS‐iCBCT, and the HS‐iCBCT and sCT dose distributions were compared by γ‐index and dose‐volume‐histogram (DVH) analysis.Results: The mean HU differences of pCT minus HS‐iCBCT (140/125 kV) were −40.97/−57.79, 9.86/21.74, and 87.22/158.20 for lung, water, and bone. In the patient cohort, the median gamma passing rates between HS‐iCBCT and sCT‐based dose calculations for 3%/2 mm and 1%/1 mm were 99.57 and 96.45% with 10% threshold, and 99.92% and 86.15% with 80% threshold. Dosimetric deviations in high dose regions were concentrated in areas with larger deformation, that is, surface change and variable bladder/bowel filling. The median (min‐max) D98%/V100% absolute deviations were 0.3(0.0–1.6)/0.0(0.0–13.7) and 0.4(0.0–1.4)/0.5(0.0–17.5) for CTVs and PTVs.Conclusions: The HS‐iCBCT platform with iterative reconstruction provides dose calculation comparable to sCT for pelvis and breast patients. However, acceptable, yet noticeable, dose discrepancies between HS‐iCBCT and sCT exist, particularly in high‐dose regions. Further investigations are needed to benchmark these methods against ground truth measurements.

29 August 2023 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
DSDennis N. Stanley
Dennis N. Stanley
ECElizabeth Covington
Elizabeth Covington
JHJoseph Harms
Joseph Harms
JPJoel Pogue
Joel Pogue
CCCarlos E. Cardenas
Carlos E. Cardenas
RPRichard A. Popple
Richard A. Popple
Purpose: With the clinical implementation of kV‐CBCT‐based daily online‐adaptive radiotherapy, the ability to monitor, quantify, and correct patient movement during adaptive sessions is paramount. With sessions lasting between 20–45 min, the ability to detect and correct for small movements without restarting the entire session is critical to the adaptive workflow and dosimetric outcome. The purpose of this study was to quantify and evaluate the correlation of observed patient movement with machine logs and a surface imaging (SI) system during adaptive radiation therapy.Methods: Treatment machine logs and SGRT registration data log files for 1972 individual sessions were exported and analyzed. For each session, the calculated shifts from a pre‐delivery position verification CBCT were extracted from the machine logs and compared to the SGRT registration data log files captured during motion monitoring. The SGRT calculated shifts were compared to the reported shifts of the machine logs for comparison for all patients and eight disease site categories.Results: The average (±STD) net displacement of the SGRT shifts were 2.6 ± 3.4 mm, 2.6 ± 3.5 mm, and 3.0 ± 3.2 in the lateral, longitudinal, and vertical directions, respectively. For the treatment machine logs, the average net displacements in the lateral, longitudinal, and vertical directions were 2.7 ± 3.7 mm, 2.6 ± 3.7 mm, and 3.2 ± 3.6 mm. The average difference (Machine–SGRT) was −0.1 ± 1.8 mm, 0.2 ± 2.1 mm, and −0.5 ± 2.5 mm for the lateral, longitudinal, and vertical directions. On average, a movement of 5.8 ± 5.6 mm and 5.3 ± 4.9 mm was calculated prior to delivery for the CBCT and SGRT systems, respectively. The Pearson correlation coefficient between CBCT and SGRT shifts was r = 0.88. The mean and median difference between the treatment machine logs and SGRT log files was less than 1 mm for all sites.Conclusion: Surface imaging should be used to monitor and quantify patient movement during adaptive radiotherapy.